The FY 2011 request for NIA is $1,142.337 million, an increase of $32.537 million or +2.9 percent over the FY 2010 enacted level. In FY 2011, NIA will support new investigators on R01 equivalent awards at success rates equivalent to those of established investigators submitting new R01 equivalent applications. NIA will continue to maintain the number of competing RPGs at nearly the same level as FY 2010. NIA is providing a 2 percent inflationary increase for non-competing and competing grants. In addition, the NIA has targeted a portion of the funds available for competing research project grants to support high priority projects outside of the pay line, including awards to new investigators, and early stage investigators. The Institute also seeks to maintain a balance between solicitations issued to the extramural community and funding made available to support investigator-initiated projects. Intramural Research and Research Management and Support receive increases to help offset pay and other costs.
Funds are included in R&D contracts to support several trans-NIH initiatives, such as the Therapies for Rare and Neglected Diseases program (TRND), the Basic Behavioral and Social Sciences Opportunity Network (OppNet), and support for a new synchrotron at the Brookhaven National Laboratory, as well as increased support for other HHS agencies through the program evaluation set-aside.